Bioprocess development workflow: Transferable physiological knowledge instead of technological correlations

Microbial bioprocesses need to be designed to be transferable from lab scale to production scale as well as between setups. Although substantial effort is invested to control technological parameters, usually the only true constant parameter is the actual producer of the product: the cell. Hence, instead of solely controlling technological process parameters, the focus should be increasingly laid on physiological parameters. This contribution aims at illustrating a workflow of data life cycle management with special focus on physiology. Information processing condenses the data into physiological variables, while information mining condenses the variables further into physiological descriptors. This basis facilitates data analysis for a physiological explanation for observed phenomena in productivity. Targeting transferability, we demonstrate this workflow using an industrially relevant Escherichia coli process for recombinant protein production and substantiate the following three points: (1) The postinduction phase is independent in terms of productivity and physiology from the preinduction variables specific growth rate and biomass at induction. (2) The specific substrate uptake rate during induction phase was found to significantly impact the maximum specific product titer. (3) The time point of maximum specific titer can be predicted by an easy accessible physiological variable: while the maximum specific titers were reached at different time points (19.8 ± 7.6 h), those maxima were reached all within a very narrow window of cumulatively consumed substrate dSn (3.1 ± 0.3 g/g). Concluding, this contribution provides a workflow on how to gain a physiological view on the process and illustrates potential benefits. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:261–270, 2017

[1]  M. Reuss,et al.  High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. , 2001, Biotechnology and bioengineering.

[2]  Oliver Spadiut,et al.  A dynamic method based on the specific substrate uptake rate to set up a feeding strategy for Pichia pastoris , 2011, Microbial cell factories.

[3]  U. Rinas,et al.  Simple fed-batch technique for high cell density cultivation of Escherichia coli. , 1995, Journal of biotechnology.

[4]  S. Lee,et al.  High cell-density culture of Escherichia coli. , 1996, Trends in biotechnology.

[5]  M. Uhlén,et al.  Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli. , 1996, Protein expression and purification.

[6]  Christoph Herwig,et al.  Information Processing: Rate-Based Investigation of Cell Physiological Changes along Design Space Development , 2012, PDA Journal of Pharmaceutical Science and Technology.

[7]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[8]  Christoph Herwig,et al.  Model-Based Analysis on the Extractability of Information from Data in Dynamic Fed-Batch Experiments , 2013, Biotechnology progress.

[9]  M. Amicosante,et al.  Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins , 2013, Microbial Cell Factories.

[10]  David Pollard,et al.  A review of advanced small‐scale parallel bioreactor technology for accelerated process development: Current state and future need , 2011, Biotechnology progress.

[11]  L. Shang,et al.  Characteristics of fed-batch cultures of recombinant Escherichia coli containing human-like collagen cDNA at different specific growth rates , 2005, Biotechnology Letters.

[12]  C. Herwig,et al.  Efficient feeding profile optimization for recombinant protein production using physiological information , 2012, Bioprocess and Biosystems Engineering.

[13]  K. Terpe.  Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems , 2006, Applied Microbiology and Biotechnology.

[14]  S. Enfors.  Control of in vivo proteolysis in the production of recombinant proteins. , 1992, Trends in biotechnology.

[15]  C. Curless,et al.  Effect of Preinduction Specific Growth Rate on Recombinant Alpha Consensus Interferon Synthesis in Escherichia coli , 1990, Biotechnology progress.

[16]  A. Norsyahida,et al.  Effects of feeding and induction strategy on the production of BmR1 antigen in recombinant E. coli , 2009, Letters in applied microbiology.

[17]  Christoph Herwig,et al.  Soft-sensor assisted dynamic investigation of mixed feed bioprocesses , 2013 .

[18]  Jonathan I. Betts,et al.  Miniature bioreactors: current practices and future opportunities , 2006, Microbial cell factories.

[19]  W. Deckwer,et al.  High cell density cultivation of Escherichia coli at controlled specific growth rate. , 1991, Journal of biotechnology.

[20]  Oliver Spadiut,et al.  A dynamic fed batch strategy for a Pichia pastoris mixed feed system to increase process understanding , 2012, Biotechnology progress.

[21]  Peter Neubauer,et al.  Limiting factors in Escherichia coli fed-batch production of recombinant proteins. , 2003, Biotechnology and bioengineering.

[22]  Andre Raw,et al.  Quality by Design: Concepts for ANDAs , 2008, The AAPS Journal.

[23]  C. Shin,et al.  High-level production of recombinant human IFN-α2a with co-expression of tRNAArg(AGG/AGA) in high-cell-density cultures ofEscherichia coli , 2001 .

[24]  Tore Hägglund,et al.  Feed rate control in fed‐batch fermentations based on frequency content analysis , 2013, Biotechnology progress.

[25]  Rimvydas Simutis,et al.  Generic model control of the specific growth rate in recombinant Escherichia coli cultivations. , 2006, Journal of biotechnology.

[26]  Carl-Fredrik Mandenius,et al.  Bioprocess optimization using design‐of‐experiments methodology , 2008, Biotechnology progress.

[27]  C. Shin,et al.  Enhanced Production of Human Mini‐Proinsulin in Fed‐Batch Cultures at High Cell Density of Escherichia coli BL21(DE3) [pET‐3aT2M2] , 1997, Biotechnology progress.